Eligard 30 mg/.5mL
Leuprolide acetate · INJECTION, SUSPENSION, EXTENDED RELEASE · TOLMAR Inc.
Eligard is a prescription injection containing leuprolide acetate, used to treat advanced prostate cancer and certain other hormone-sensitive conditions by suppressing testosterone production. This extended-release formulation is given as a subcutaneous injection and is designed to provide medication effects over an extended period.
Key Facts
- Brand Name
- Eligard
- Generic Name
- Leuprolide acetate
- NDC Code (Product)
62935-306- Manufacturer
- TOLMAR Inc.
- Strength
- 30 mg/.5mL
- Dosage Form
- INJECTION, SUSPENSION, EXTENDED RELEASE
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- NDA021488
- Marketing Start
- 01/11/2024
Recall History
No Recall HistoryFrequently Asked Questions
What is Eligard used for?
Eligard is a prescription injection containing leuprolide acetate, used to treat advanced prostate cancer and certain other hormone-sensitive conditions by suppressing testosterone production. This extended-release formulation is given as a subcutaneous injection and is designed to provide medication effects over an extended period.
Is Eligard a controlled substance?
Eligard is not classified as a controlled substance by the DEA.
What is the generic name for Eligard?
The generic name for Eligard is Leuprolide acetate. There are 10 other brand versions of Leuprolide acetate.
What is the NDC code for Eligard 30 mg/.5mL?
The NDC (National Drug Code) for Eligard 30 mg/.5mL is 62935-306, listed by TOLMAR Inc..